January 13th, 2015|
Laws regulate the testing procedures medications bound for the U.S. marketplace must undergo to ensure safety. However, overseeing these regulations with a limited staff has proven daunting for the U.S. Food and Drug Administration (FDA) in recent years. That’s why the agency launched the Office of Pharmaceutical Quality to help reduce drug injury numbers.
The Regulatory Affairs Professionals Society reports that the FDA announced the creation of the office in 2012, but it took several years for the organization to come to fruition. Two of the main tasks the office has clearly stated it plans to address are shortages in drug manufacturing and a lack of modernization in manufacturing techniques, the latter of which could significantly improve drug safety in the United States.
The new branch is now responsible for approving or denying more than 10,000 drug applications each year and could bring predictability in the approval process to drug manufacturers.
At Norris Injury Lawyers, we recognize the dangers taking certain medications can pose. That’s why our Birmingham personal injury attorneys are hopeful the new system is a success.